Large-scale testing (Phase 3)Study completedNCT01371721
What this trial is testing
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
Who this might be right for
Major Depressive Disorder
Pfizer 269